Clinical Trial Update: Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD [Phase 2]

View source ↗

Summary

A Phase 2 classroom-based study evaluating the efficacy and safety of MTS in children aged 6-12 with ADHD has completed. The trial was sponsored by Noven Therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• MTS

Snippet

Sponsor: Noven Therapeutics | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 2 | Status: COMPLETED